About cardiovascular implants
Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart failure are some of the major cardiac diseases. The contraction or obstruction of blood vessels, especially coronary arteries, is one of the most common reasons for cardiac diseases. Cardiovascular implants are widely used for the treatment of cardiac diseases. Cardiovascular implants are made up of different materials such as metals and its alloys, polymers, and biological materials. There are various cardiovascular implants such as CRTs, ICDs, ICPs, coronary stents, peripheral stents, and heart valves.
Technavio's analysts forecast the global cardiovascular implants market to grow at a CAGR of 4.54% over the period 2014-2019.
Covered in this report
This report covers the present and future scenario of the global cardiovascular implants market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of cardiovascular implants.
Technavio's report, Global Cardiovascular Implants Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
• Americas
• APAC
• EMEA
Key vendors
• Abbott Laboratories
• Boston Scientific
• Medtronic
• St. Jude Medical
Other prominent vendors
• AMG International
• Biotronik
• B-Braun
• Cardiac Dimension
• Cardiac Science
• Edwards Lifesciences
• Fortimedix
• Neovasc
• On-X Life Technologies
• Pacetronix
• Proxy Biomedical
• Reva Medical
• Sorin
• W.L. Gore & Associates
Market driver
Growing incidence of cardiovascular disorders
For a full, detailed list, view our report
Market challenge
High cost
For a full, detailed list, view our report
Market trend
Growing popularity of robotic assistance surgeries
For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Cardiovascular implant materials
PART 07: Cardiovascular implants regulatory classification
PART 08: Cardiovascular implants: Product recalls
PART 09: Market segmentation by product
Global CRT devices market
Global ICD market
Global implanted cardiac pacemaker market
Global coronary stent market
Global peripheral stent market
Global heart valve market
PART 10: Average cost of cardiovascular implant surgeries
PART 11: Geographical segmentation
Cardiovascular implants market in Americas
Cardiovascular implants market in EMEA
Cardiovascular implants market in APAC
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 18: Key vendor analysis
Abbott Laboratories
Boston Scientific
Medtronic
St. Jude Medical
PART 19: Appendix
List of abbreviations
PART 20: Explore Technavio
List Of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global cardiovascular implants market 2014-2019 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Types of materials
Exhibit 05: Properties of polymers
Exhibit 06: Comparison of allograft and xenograft
Exhibit 07: US FDA and EU regulatory agencies: Pathway for Class III devices
Exhibit 08: Recalls of cardiovascular implants
Exhibit 09: Reasons for cardiovascular implant recalls
Exhibit 10: Global cardiovascular implants market segmentation by product
Exhibit 11: Global CRT market 2014-2019 ($ billions)
Exhibit 12: Global ICD market 2014-2019 ($ billions)
Exhibit 13: Global coronary stent market 2014-2019 ($ billions)
Exhibit 14: Global coronary stent market 2014-2019 ($ billions)
Exhibit 15: Global peripheral stent market 2014-2019 ($ billions)
Exhibit 16: Global heart valve market 2014-2019 ($ billions)
Exhibit 17: Global cardiovascular implants market by product 2014-2019
Exhibit 18: Global cardiovascular implants market by product 2014-2019 ($ billions)
Exhibit 19: Cost of cardiovascular implant surgeries 2014
Exhibit 20: Global cardiovascular implants market segmentation by geography
Exhibit 21: Changes in an individual during aging process
Exhibit 22: Impact of drivers
Exhibit 23: Impact of drivers and challenges
Exhibit 24: Ranking of top vendors 2014
Exhibit 25: Medtronic: Key takeaways
Exhibit 26: Boston Scientific: Key takeaways
Exhibit 27: St. Jude Medical: Key takeaways
Exhibit 28: Abbott Laboratories: Key takeaways
Exhibit 29: Product portfolio of major vendors
Exhibit 30: Abbott Laboratories: Business segmentation by revenue 2014
Exhibit 31: Abbott Laboratories: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 32: Abbott Laboratories: Geographical segmentation by revenue 2014
